NCT05866822 Adapted Physical Activity Education in Patients With Neurocognitive Disorder
| NCT ID | NCT05866822 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Neurocognitive Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2024-01-05 |
| Primary Completion | 2026-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2024-01-05 with a primary completion date of 2026-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effect of a program of Adapted Physical Activity (APA) versus the same program combined with a physical activity education program (PAE). Patients suffering from neurocognitive disorders (mild or early major) will be randomized into one of the two conditions. 3 complete evaluations will be done (inclusion M0, after 3 month of intervention M3, 3 months after the end of the intervention M6). The team except that APA+PEA will be more effectiv than the APA solely, on the following criteria : level of physical activity, cogntive function and quality of life.
Eligibility Criteria
Inclusion Criteria: * mild neurocognitive disorder or early major neurocognitive disorder Exclusion Criteria: * Medical pathology involving the vital prognosis in the short term * Major neurocognitive disorder at moderate stage and beyond (DSM 5) and/or MMSE \< 20 * Unbalanced depressive syndrom * Contraindication to the practice of the exercises proposed during the study; * Major hearing or visual impairment; * Sufficiently active with regard to the daily recommendations described by the WHO
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05866822 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Neurocognitive Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05866822 currently recruiting?
Yes, NCT05866822 is actively recruiting participants. Contact the research team at lemaire.j@chu-nice.fr for enrollment information.
Where is the NCT05866822 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT05866822 clinical trial?
NCT05866822 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 34 participants.